CenterBook Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,616
Closed -$965K 489
2024
Q4
$965K Sell
10,616
-51,329
-83% -$4.9M 0.06% 339
2024
Q3
$6.43M Buy
+61,945
New +$6.31M 0.4% 79
2023
Q4
Sell
-16,661
Closed -$1.18M 405
2023
Q3
$1.18M Buy
16,661
+3,839
+30% +$287K 0.15% 224
2023
Q2
$988K Sell
12,822
-1,138
-8% -$88.1K 0.12% 245
2023
Q1
$1.05M Sell
13,960
-2,859
-17% -$213K 0.15% 227
2022
Q4
$1.33M Buy
16,819
+1,139
+7% +$85.4K 0.22% 162
2022
Q3
$1.1M Buy
15,680
+9,771
+165% +$766K 0.21% 163
2022
Q2
$474K Sell
5,909
-857
-13% -$67K 0.1% 277
2022
Q1
$513K Buy
+6,766
New +$536K 0.18% 199

Other funds holding CL

CenterBook Partners's CL Position: Q1 2025 in Review

CenterBook Partners sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 10,616 shares — an estimated $965K sold.

CenterBook Partners first reported a position in CL in Q1 2022 and held it in 9 quarters. The position peaked at $6.43M in Q3 2024. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • CenterBook Partners reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
  • CenterBook Partners sold 10,616 Colgate-Palmolive shares in Q1 2025, an estimated $965K.
  • CenterBook Partners first reported a position in Colgate-Palmolive in Q1 2022 and held it in 9 quarters.
  • CenterBook Partners's Colgate-Palmolive position peaked at $6.43M in Q3 2024.
  • 1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on CenterBook Partners's 13F filing for Q1 2025, filed 9 May 2025.